Results
|
14941.
|
|
|
14942.
|
|
|
14943.
|
|
|
14944.
|
|
|
14945.
|
|
|
14946.
|
|
|
14947.
|
|
|
14948.
|
|
|
14949.
|
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy. [electronic resource] by
- Clemons, Mark J
- Dranitsaris, George
- Ooi, Wei S
- Yogendran, Geetha
- Sukovic, Tatjana
- Wong, Betty Y L
- Verma, Sunil
- Pritchard, Kathleen I
- Trudeau, Maureen
- Cole, David E C
Producer: 20061106
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 24
Availability: No items available.
|
|
14950.
|
|
|
14951.
|
|
|
14952.
|
|
|
14953.
|
|
|
14954.
|
|
|
14955.
|
|
|
14956.
|
|
|
14957.
|
|
|
14958.
|
|
|
14959.
|
|
|
14960.
|
|